Search research articles
Contact Us
Filters
Showing results (131-140 of 159) with videos related to
Page
of 16
Sort By:
Journal of Translational Medicine
|
May 30, 2020
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer
Stephen T Ryan, Jing Zhang, Danielle N Burner, et al.
Mucosal Immunology
|
November 20, 2014
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
J F Vázquez-Castellanos, S Serrano-Villar, A Latorre, et al.
Mucosal Immunology
|
December 22, 2016
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects
S Serrano-Villar, J F Vázquez-Castellanos, A Vallejo, et al.
Genome Medicine
|
July 31, 2019
Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Francesca Finotello, Clemens Mayer, Christina Plattner, et al.
Cell Metabolism
|
October 6, 2017
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Kyung-Min Lee, Jennifer M Giltnane, Justin M Balko, et al.
Journal of Nursing Regulation
|
September 13, 2021
Leading Policy and Practice Change During Unprecedented Times: The Nursing Health Services Research Response
Hayley Germack, Michael Cary, Heather Gilmartin, et al.
Genome Medicine
|
May 26, 2019
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Francesca Finotello, Clemens Mayer, Christina Plattner, et al.
Nutricion Hospitalaria
|
April 10, 2007
Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient
R Polo, C Gómez-Candela, C Miralles, et al.
HIV Medicine
|
August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patients
R Teira, F Vidal, P Muñoz-Sánchez, et al.
Nature Communications
|
January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
Douglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 159) with videos related to
Sort By:
Page
of 16
Journal of Translational Medicine
|
May 30, 2020
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer
Stephen T Ryan, Jing Zhang, Danielle N Burner, et al.
Mucosal Immunology
|
November 20, 2014
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
J F Vázquez-Castellanos, S Serrano-Villar, A Latorre, et al.
Mucosal Immunology
|
December 22, 2016
The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects
S Serrano-Villar, J F Vázquez-Castellanos, A Vallejo, et al.
Genome Medicine
|
July 31, 2019
Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Francesca Finotello, Clemens Mayer, Christina Plattner, et al.
Cell Metabolism
|
October 6, 2017
MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation
Kyung-Min Lee, Jennifer M Giltnane, Justin M Balko, et al.
Journal of Nursing Regulation
|
September 13, 2021
Leading Policy and Practice Change During Unprecedented Times: The Nursing Health Services Research Response
Hayley Germack, Michael Cary, Heather Gilmartin, et al.
Genome Medicine
|
May 26, 2019
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
Francesca Finotello, Clemens Mayer, Christina Plattner, et al.
Nutricion Hospitalaria
|
April 10, 2007
Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient
R Polo, C Gómez-Candela, C Miralles, et al.
HIV Medicine
|
August 2, 2016
Very low level viraemia and risk of virological failure in treated HIV-1-infected patients
R Teira, F Vidal, P Muñoz-Sánchez, et al.
Nature Communications
|
January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
Douglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Page
of 16